Hikma’s US Biosimilars Ambitions Begin With $150m Ustekinumab Deal

Firm Signs Commercialization and License Agreement With Bio-Thera Solutions

 
• By Dean Rudge
  
Deals Sign
Hikma has signed a US deal, following several in the MENA region • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products